CRESCENT BIOPHARMA, INC. Basic Shares Outstanding (Weighted Average)
CRESCENT BIOPHARMA, INC. (CBIO) reported Basic Shares Outstanding (Weighted Average) of 64.52 million shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2025-05-14
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 64.52M shares, a 0.10% increase year-over-year.
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2024-12-31 was 64.48M shares, a 0.14% increase year-over-year.
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2024-09-30 was 64.48M shares, a 0.21% increase year-over-year.
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2024-06-30 was 64.48M shares, a 0.32% increase year-over-year.
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 64.48M shares, a 1.79% increase from fiscal 2023.
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 63.34M shares, a 20.58% increase from fiscal 2022.
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 52.53M shares, a 2.10% increase from fiscal 2021.
- CRESCENT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 51.45M shares, a 12.54% increase from fiscal 2020.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2025-03-31 | 64.52M shares 10-Q · filed 2025-05-14 | 64.50M shares derived: average of 2 quarters · filed 2025-05-14 | 64.50M shares derived: average of 3 quarters · filed 2025-05-14 | 64.49M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 64.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 64.48M shares derived: average of 2 quarters · filed 2025-02-13 | 64.48M shares derived: average of 3 quarters · filed 2025-02-13 | 64.48M shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 64.48M shares 10-Q · filed 2024-11-13 | 64.48M shares derived: average of 2 quarters · filed 2024-11-13 | 64.48M shares 10-Q · filed 2024-11-13 | 64.45M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | 64.48M shares 10-Q · filed 2024-08-08 | 64.47M shares 10-Q · filed 2024-08-08 | 64.44M shares derived: average of 3 quarters · filed 2025-05-14 | 64.42M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | 64.46M shares 10-Q · filed 2025-05-14 | 64.43M shares derived: average of 2 quarters · filed 2025-05-14 | 64.40M shares derived: average of 3 quarters · filed 2025-05-14 | 64.37M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 64.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 64.37M shares derived: average of 2 quarters · filed 2025-02-13 | 64.34M shares derived: average of 3 quarters · filed 2025-02-13 | 63.34M shares 10-K · filed 2025-02-13 |
| 2023-09-30 | 64.35M shares 10-Q · filed 2024-11-13 | 64.31M shares derived: average of 2 quarters · filed 2024-11-13 | 62.99M shares 10-Q · filed 2024-11-13 | 60.48M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 64.28M shares 10-Q · filed 2024-08-08 | 62.31M shares 10-Q · filed 2024-08-08 | 59.20M shares derived: average of 3 quarters · filed 2024-08-08 | 57.50M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 60.35M shares 10-Q · filed 2024-05-09 | 56.66M shares derived: average of 2 quarters · filed 2024-05-09 | 55.25M shares derived: average of 3 quarters · filed 2024-05-09 | 54.54M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 52.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 52.69M shares derived: average of 2 quarters · filed 2024-03-27 | 52.60M shares derived: average of 3 quarters · filed 2024-03-27 | 52.53M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 52.42M shares 10-Q · filed 2023-11-03 | 52.42M shares derived: average of 2 quarters · filed 2023-11-03 | 52.39M shares 10-Q · filed 2023-11-03 | 52.29M shares derived: average of 4 quarters · filed 2024-03-27 |
| 2022-06-30 | 52.41M shares 10-Q · filed 2023-08-02 | 52.37M shares 10-Q · filed 2023-08-02 | 52.25M shares derived: average of 3 quarters · filed 2024-03-27 | 52.08M shares derived: average of 4 quarters · filed 2024-03-27 |
| 2022-03-31 | 52.33M shares 10-Q · filed 2023-05-03 | 52.17M shares derived: average of 2 quarters · filed 2024-03-27 | 51.97M shares derived: average of 3 quarters · filed 2024-03-27 | 51.86M shares derived: average of 4 quarters · filed 2024-03-27 |
| 2021-12-31 | 52.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 51.79M shares derived: average of 2 quarters · filed 2024-03-27 | 51.71M shares derived: average of 3 quarters · filed 2024-03-27 | 51.45M shares 10-K · filed 2024-03-27 |
| 2021-09-30 | 51.56M shares 10-Q · filed 2022-11-09 | 51.55M shares derived: average of 2 quarters · filed 2022-11-09 | 51.27M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 51.54M shares 10-Q · filed 2022-08-03 | 51.12M shares 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | 50.70M shares 10-Q · filed 2022-04-28 | |||
| 2020-12-31 | 45.72M shares 10-K · filed 2023-03-29 | |||
| 2019-12-31 | 43.25M shares 10-K · filed 2022-03-03 | |||
| 2016-06-30 | 19.79M shares 10-Q · filed 2016-08-04 | 19.43M shares 10-Q · filed 2016-08-04 | ||
| 2015-09-30 | 19.03M shares 10-Q · filed 2015-11-12 | 19.02M shares derived: average of 2 quarters · filed 2016-08-04 | 19.00M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 19.01M shares 10-Q · filed 2016-08-04 | 18.99M shares 10-Q · filed 2016-08-04 | ||
| 2014-12-31 | 18.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 18.88M shares derived: average of 2 quarters · filed 2015-11-12 | 18.86M shares derived: average of 3 quarters · filed 2015-11-12 | 18.45M shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 18.89M shares 10-Q · filed 2015-11-12 | 18.85M shares derived: average of 2 quarters · filed 2015-11-12 | 18.31M shares 10-Q · filed 2015-11-12 | |
| 2014-06-30 | 18.81M shares 10-Q · filed 2015-08-06 | 18.02M shares 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | 17.23M shares 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | 1.20M shares 10-K · filed 2015-03-16 | |||
| 2013-06-30 | 946.36K shares 10-Q · filed 2014-07-31 | 938.45K shares 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | 930.53K shares 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | 929.62K shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |